Applied Therapeutics Inc.

Applied Therapeutics Inc. price momentum is very positive. Applied Therapeutics Inc. is not a good value stock. Applied Therapeutics Inc. is not very popular among insiders. Applied Therapeutics Inc. is a mediocre stock to choose.
Log in to see more information.

News

Applied Therapeutics: Pushing Towards FDA Approval
Applied Therapeutics: Pushing Towards FDA Approval

SeekingAlpha Applied Therapeutics: Pushing Towards FDA Approval...\n more…

Applied Therapeutics to Participate in Upcoming Investor Conferences
Applied Therapeutics to Participate in Upcoming Investor Conferences

Globe Newswire NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...\n more…

Peregrine Capital Management LLC Takes $3.41 Million Position in Applied Therapeutics, Inc. (NASDAQ:APLT)
Peregrine Capital Management LLC Takes $3.41 Million Position in Applied Therapeutics, Inc. (NASDAQ:APLT)

Zolmax Peregrine Capital Management LLC purchased a new stake in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) in the 2nd quarter, Holdings Channel.com reports. The firm purchased 731,048 shares...\n more…

Peregrine Capital Management LLC Purchases Shares of 731,048 Applied Therapeutics, Inc. (NASDAQ:APLT)
Peregrine Capital Management LLC Purchases Shares of 731,048 Applied Therapeutics, Inc. (NASDAQ:APLT)

Ticker Report Peregrine Capital Management LLC purchased a new stake in shares of Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) in the second quarter, according to its most recent filing with the...\n more…

SG Americas Securities LLC Makes New Investment in Applied Therapeutics, Inc. (NASDAQ:APLT)
SG Americas Securities LLC Makes New Investment in Applied Therapeutics, Inc. (NASDAQ:APLT)

Ticker Report SG Americas Securities LLC acquired a new stake in shares of Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and...\n more…

Applied Therapeutics price target raised by $1 at Citi, here's why
Applied Therapeutics price target raised by $1 at Citi, here's why

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…